
Impact of Cytochrome P450 (CYP) 3A5 genetic polymorphism on tacrolimus doses and concentration/dose ratio in renal transplant recipients.
Author(s) -
Andrew McLaren
Publication year - 2003
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000091125.73504.e3
Subject(s) - tacrolimus , immunosuppression , pharmacology , pharmacogenetics , calcineurin , transplantation , cyp3a4 , medicine , therapeutic drug monitoring , prednisolone , organ transplantation , immunosuppressive drug , therapeutic index , drug , biology , cytochrome p450 , metabolism , genotype , genetics , gene